American investment firm Carlyle Group is planning to divest a 3% stake in India-based SBI Life Insurance Company.
The deal, according to The Economic Times, could fetch as much INR28.2bn ($393.1m) for the Carlyle Group.
Go deeper with GlobalData
Each share will be sold at around INR930 ($12.97) to INR940 (13.11), a 6% to 7% discount over Monday’s closing price of INR1,000 ($13.94) on 18 November, the report added.
Carlyle Group, through its investment unit CA Emerald Investments, acquired a 9% stake in SBI Life Insurance from BNP Paribas Cardif in a transaction valued at around INR55bn ($776.22m) in March this year.
Last month, private equity firm KKR also sold shares worth about $75m that it held in SBI Life Insurance.
In June, BNP Paribas Cardif revealed its plans to offload up to 25 million shares, representing around 2.5% of SBI Life Insurance in a transaction worth INR16.25bn ($235m).
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataSBI Life is a joint venture (JV) between India’s largest bank State Bank of India and BNP Paribas Cardif, a unit of French lender BNP.
As of 30 September 2019, SBI held a nearly 57.6% stake in the JV, while BNP Paribas owned around 5.2% stake.
Investment bank JP Morgan has been hired by Carlyle Group to advise on the block deal.
Founded in 2001, SBI Life Insurance has a unique multi-distribution model encompassing bancassurance, retail agency, institutional alliance, and corporate solutions. It offers a range of life, health, pension, on-line and micro-insurance products.
